Myriad Genetics, Inc. (MYGN)
3.18
+0.06
(+1.92%)
USD |
NASDAQ |
Aug 27, 16:00
3.175
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics Debt to Equity Ratio : 0.6927 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.6927 |
| March 31, 2026 | 0.6269 |
| December 31, 2025 | 0.5701 |
| September 30, 2025 | 0.5695 |
| June 30, 2025 | 0.3984 |
| March 31, 2025 | 0.2236 |
| December 31, 2024 | 0.2001 |
| September 30, 2024 | 0.1956 |
| June 30, 2024 | 0.1935 |
| March 31, 2024 | 0.1932 |
| December 31, 2023 | 0.1942 |
| September 30, 2023 | 0.2947 |
| June 30, 2023 | 0.2772 |
| March 31, 2023 | 0.1935 |
| December 31, 2022 | 0.1637 |
| September 30, 2022 | 0.1498 |
| June 30, 2022 | 0.1063 |
| March 31, 2022 | 0.0946 |
| December 31, 2021 | 0.0954 |
| September 30, 2021 | 0.0965 |
| June 30, 2021 | 0.2224 |
| March 31, 2021 | 0.2484 |
| June 30, 2020 | 0.3211 |
| March 31, 2020 | 0.304 |
| December 31, 2019 | 0.2753 |
| Date | Value |
|---|---|
| September 30, 2019 | 0.2798 |
| June 30, 2019 | 0.2144 |
| March 31, 2019 | 0.2435 |
| December 31, 2018 | 0.2568 |
| September 30, 2018 | 0.2341 |
| June 30, 2018 | 0.0096 |
| March 31, 2018 | 0.0731 |
| December 31, 2017 | 0.0473 |
| September 30, 2017 | 0.0852 |
| June 30, 2017 | 0.1273 |
| March 31, 2017 | 0.2233 |
| December 31, 2016 | 0.2783 |
| September 30, 2016 | 0.2708 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Natera, Inc. | 0.1309 |
| Sera Prognostics, Inc. | 0.0505 |
| BioRestorative Therapies, Inc. | 0.0114 |
| CareDx, Inc. | 0.0452 |
| Exagen, Inc. | 2.264 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 638.90M |
| Total Liabilities (Quarterly) | 335.00M |
| Shareholders Equity (Quarterly) | 303.90M |
| Current Ratio | 2.211 |
| Net Debt Paydown Yield | -1.94% |